Antitumor activity of new pyrazolo[3,4-d]pyrimidine SRC kinase inhibitors in Burkitt lymphoma cell lines and its enhancement by WEE1 inhibition
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Antitumor activity of new pyrazolo[3,4-d]pyrimidine SRC kinase inhibitors in Burkitt lymphoma cell lines and its enhancement by WEE1 inhibition
Authors
Keywords
-
Journal
CELL CYCLE
Volume 11, Issue 5, Pages 1029-1039
Publisher
Informa UK Limited
Online
2012-03-07
DOI
10.4161/cc.11.5.19519
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MK-1775, a small molecule Wee1 inhibitor, enhances anti-tumor efficacy of various DNA-damaging agents, including 5-fluorouracil
- (2010) Hiroshi Hirai et al. CANCER BIOLOGY & THERAPY
- Novel dual Src/Abl inhibitors for hematologic and solid malignancies
- (2010) Silvia Schenone et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- New pyrazolo-[3,4-d]-pyrimidine derivative Src kinase inhibitors lead to cell cycle arrest and tumor growth reduction of human medulloblastoma cells
- (2010) Alessandra Rossi et al. FASEB JOURNAL
- The molecular background of aggressive B cell lymphomas as a basis for targeted therapy
- (2010) Daphne de Jong et al. JOURNAL OF PATHOLOGY
- Selective killing of Burkitt's lymphoma cells by mBAFF-targeted delivery of PinX1
- (2010) L Zhang et al. LEUKEMIA
- Anomalous constitutive Src kinase activity promotes B lymphoma survival and growth
- (2010) Jiyuan Ke et al. Molecular Cancer
- Inhibition of Src with AZD0530 Reveals the Src-Focal Adhesion Kinase Complex as a Novel Therapeutic Target in Papillary and Anaplastic Thyroid Cancer
- (2009) Rebecca E. Schweppe et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Therapeutic implications of Src independent calcium mobilization in diffuse large B-cell lymphoma
- (2009) C. Annette Hollmann et al. LEUKEMIA RESEARCH
- Small-molecule inhibition of Wee1 kinase by MK-1775 selectively sensitizes p53-deficient tumor cells to DNA-damaging agents
- (2009) H. Hirai et al. MOLECULAR CANCER THERAPEUTICS
- AKT inhibitor, GSK690693, induces growth inhibition and apoptosis in acute lymphoblastic leukemia cell lines
- (2008) D. S. Levy et al. BLOOD
- AXL Is a Potential Target for Therapeutic Intervention in Breast Cancer Progression
- (2008) Y.-X. Zhang et al. CANCER RESEARCH
- Synthesis, biological evaluation and docking studies of 4-amino substituted 1H-pyrazolo[3,4-d]pyrimidines
- (2008) Silvia Schenone et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Antiproliferative and proapoptotic activities of new pyrazolo[3,4-d]pyrimidine derivative Src kinase inhibitors in human osteosarcoma cells
- (2008) Adriano Spreafico et al. FASEB JOURNAL
- Src Directly Phosphorylates Bif-1 and Prevents Its Interaction with Bax and the Initiation of Anoikis
- (2008) Hirohito Yamaguchi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started